Brian Cahill

2021

In 2021, Brian Cahill earned a total compensation of $1.9M as Chief Financial Officer at Eagle Pharmaceuticals, a 2% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$373,920
Salary$380,000
Stock Awards$1,071,649
Other$30,042
Total$1,855,611

Cahill received $1.1M in stock awards, accounting for 58% of the total pay in 2021.

Cahill also received $373.9K in non-equity incentive plan, $380K in salary and $30K in other compensation.

Rankings

In 2021, Brian Cahill's compensation ranked 6,340th out of 12,415 executives tracked by ExecPay. In other words, Cahill earned more than 48.9% of executives.

ClassificationRankingPercentile
All
6,340
out of 12,415
49th
Division
Manufacturing
2,700
out of 5,505
51st
Major group
Chemicals And Allied Products
1,187
out of 2,375
50th
Industry group
Drugs
1,057
out of 2,096
50th
Industry
Pharmaceutical Preparations
766
out of 1,546
51st

Pay ratio

Brian Cahill's Pay$1,855,611
Median Employee's Pay$246,233
Pay Ratio

8

to 1

In 2021, the annual total compensation of Brian Cahill was $1,855,611.

The annual total compensation of the median employee at Eagle Pharmaceuticals was $246,233.

The ratio of Brian Cahill's pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on June 15, 2022.

Cahill's colleagues

We found four more compensation records of executives who worked with Brian Cahill at Eagle Pharmaceuticals in 2021.

2021

Scott Tarriff

Eagle Pharmaceuticals

Chief Executive Officer

2021

David Pernock

Eagle Pharmaceuticals

Chief Operating Officer

2021

Michael Moran

Eagle Pharmaceuticals

Chief Commercial Officer

2021

Judith Ng-Cashin

Eagle Pharmaceuticals

Chief Medical Officer

News

You may also like